Implantable Defibrillator System Shock Function, Mortality, and Cause of Death After Magnetic Resonance Imaging

被引:0
|
作者
Ra, Joshua [1 ,6 ]
Oberdier, Matt T. T. [2 ]
Suzuki, Masahito [2 ]
Vaidya, Dhananjay [2 ]
Liu, Yisi [3 ]
Hansford, Rozann [2 ]
McVeigh, Diana [2 ]
Weltin, Valeria [2 ]
Tao, Susumu [2 ]
Thiemann, David R. [2 ]
Nazarian, Saman [4 ]
Halperin, Henry R. [5 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Johns Hopkins Univ, Dept Cardiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Pediat, Baltimore, MD USA
[4] Univ Penn Perelman, Sch Med, Dept Cardiol, Philadelphia, PA USA
[5] Johns Hopkins Univ, Dept Cardiol, Dept Radiol & Biomed Engn, Baltimore, MD USA
[6] Univ Calif San Francisco, Dept Med, 521 Parnassus Ave, San Francisco, CA 94143 USA
基金
美国国家卫生研究院;
关键词
INDUSTRY VIEWPOINT; SAFE PERFORMANCE; CARDIOVERTER-DEFIBRILLATORS; CLINICAL SAFETY; ABSORPTION RATE; PACEMAKERS; MRI; ICDS; PROTOCOL; DEVICES;
D O I
10.7326/M22-2653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Studies have shown that magnetic resonance imaging (MRI) does not have clinically important effects on the device parameters of non-MRI-conditional implantable cardioverter-defibrillators (ICDs). However, data on non-MRI-conditional ICD detection and treatment of arrhythmias after MRI are limited.Objective: To examine if non-MRI-conditional ICDs have preserved shock function of arrhythmias after MRI.Design: Prospective cohort study. (ClinicalTrials.gov: NCT01130896)Setting: 1 center in the United States.Patients: 629 patients with non-MRI-conditional ICDs enrolled consecutively between February 2003 and January 2015.Interventions: 813 total MRI examinations at a magnetic field strength of 1.5 Tesla using a prespecified safety protocol.Measurements: Implantable cardioverter-defibrillator inter-rogations were collected after MRI. Clinical outcomes included arrhythmia detection and treatment, generator or lead exchanges, adverse events, and death.Results: During a median follow-up of 2.2 years from MRI to latest available ICD interrogation before generator or lead exchange in 536 patients, 4177 arrhythmia episodes were detected, and 97 patients received ICD shocks. Sixty-one patients (10% of total) had 130 spontaneous ventricular tachycardia or fibrillation events terminated by ICD shocks. A total of 210 patients (33% of total) are known to have died (median, 1.7 years from MRI to death); 3 had cardiac arrhythmia deaths where shocks were indicated without direct evidence of device dysfunction.Limitations: Data were acquired at a single center and may not be generalizable to other clinical settings and MRI facilities. Implantable cardioverter-defibrillator interrogations were not avail-able for a subset of patients; adjudication of cause of death relied solely on death certificate data in a subset.Conclusion: Non-MRI-conditional ICDs appropriately treated detected tachyarrhythmias after MRI. No serious adverse effects on device function were reported after MRI.
引用
收藏
页码:289 / 297
页数:10
相关论文
共 50 条
  • [1] Functionality of implantable defibrillators after magnetic resonance imaging, mortality and causes of death
    Jaeger, D.
    ANNALES FRANCAISES DE MEDECINE D URGENCE, 2023, 13 (04): : 270 - 271
  • [2] Implantable cardioverter defibrillator dysfunction during and after magnetic resonance imaging
    Anfinsen, OG
    Berntsen, RF
    Aass, H
    Kongsgaard, E
    Amlie, JP
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2002, 25 (09): : 1400 - 1402
  • [3] Magnetic resonance imaging in a patient with an implantable cardiac defibrillator
    Furusho, Hiroshi
    Kusayama, Takashi
    Chikata, Akio
    Kobayashi, Daisuke
    Murai, Hisayoshi
    Usui, Soichiro
    Okajima, Masaki
    Kaneko, Shuichi
    Yamagishi, Masakazu
    Takamura, Masayuki
    JOURNAL OF ARRHYTHMIA, 2012, 28 (06) : 353 - 355
  • [4] Image Quality of Cardiac Magnetic Resonance Imaging in Patients With an Implantable Cardioverter Defibrillator System Designed for the Magnetic Resonance Imaging Environment
    Schwitter, Juerg
    Gold, Michael R.
    Al Fagih, Ahmed
    Lee, Sung
    Peterson, Michael
    Ciuffo, Allen
    Zhang, Yan
    Kristiansen, Nina
    Kanal, Emanuel
    Sommer, Torsten
    CIRCULATION-CARDIOVASCULAR IMAGING, 2016, 9 (05)
  • [5] Magnetic resonance imaging in a patient with an implantable cardioverter-defibrillator
    Fijalkowski, Marcin
    Mielczarek, Maksymilian
    Szurowska, Edyta
    Zacharek, Dariusz
    Kempa, Maciej
    Dorniak, Karolina
    Bohdan, Michal
    Sabisz, Agnieszka
    Dubaniewicz, Miroslawa
    Rynkiewicz, Andrzej
    KARDIOLOGIA POLSKA, 2013, 71 (06) : 618 - 620
  • [6] Mortality After Magnetic Resonance Imaging of the Brain in Patients With Cardiovascular Implantable Devices
    Padmanabhan, Deepak
    Jondal, Mary L.
    Hodge, David O.
    Mehta, Ramila A.
    Acker, Nancy G.
    Dalzell, Connie M.
    Kapa, Suraj
    Asirvatham, Samuel J.
    Cha, Yong-Mei
    Felmlee, Joel P.
    Watson, Robert E., Jr.
    Friedman, Paul A.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2018, 11 (01):
  • [7] Cardiac magnetic resonance imaging in a patient with implantable cardioverter-defibrillator
    Roguin, A
    Donahue, JK
    Bomma, CS
    Bluemke, DA
    Halperin, HR
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2005, 28 (04): : 336 - 338
  • [8] Implantable cardiac defibrillator interactions with magnetic resonance imaging at 1.5 Tesla
    Coman, JA
    Martin, ET
    Sandler, DA
    Thomas, JR
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 138A - 138A
  • [9] Magnetic resonance imaging in patients with a subcutaneous implantable cardioverter-defibrillator
    Keller, Jiri
    Neuzil, Petr
    Vymazal, Josef
    Janotka, Marek
    Brada, Jiri
    Zacek, Radovan
    Vopalka, Roman
    Weichet, Jiri
    Reddy, Vivek Y.
    EUROPACE, 2015, 17 (05): : 761 - 766
  • [10] Suppression of implantable cardioverter defibrillator therapy during magnetic resonance imaging
    Nemec, J
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2006, 17 (04) : 444 - 445